title: Early prognosis of acute asthma in the emergency room.
abstract: OBJECTIVE
  To evaluate clinical and pulmonary function measurements taken in the first fifteen minutes of the assessment of acute asthma in the emergency room and used for prognostic purposes.
  
  
  METHODS
  A prospective cohort study involving consecutive patients with acute asthma. Only patients who were between the ages of 12 and 55 and presented peak expiratory flow rates < or = 50% of predicted were included. Evaluations were performed upon admission, then again at 15 minutes and 4 hours after the initiation of treatment. Treatment included albuterol and ipratropium delivered by metered-dose inhaler with a spacer, together with 100 mg of intravenous hydrocortisone. Favorable outcomes were defined as peak expiratory flow > or = 50% of predicted after 4 hours of treatment, and unfavorable outcomes were defined as peak expiratory flow < 50% after 4 hours of treatment.
  
  
  RESULTS
  Favorable outcomes were seen in 27 patients, and unfavorable outcomes were seen in 24 patients. In the multivariate analysis, peak expiratory flow as percentage of predicted was identified as the variable with the highest predictive value. A peak expiratory flow > or = 40% after 15 minutes of treatment showed significant power in predicting a favorable outcome (sensitivity = 0.74, specificity = 1.00, and positive predictive value = 1.00). A peak expiratory flow < 30% after 15 minutes of treatment was predictive of a poor outcome (sensitivity = 0.54, specificity = 0.93, and positive predictive value = 0.87).
  
  
  CONCLUSIONS
  Our results suggest that measuring peak expiratory flow after 15 minutes of management in the emergency room is a useful tool for predicting outcomes in cases of acute asthma.
authors.affiliation: Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.
authors.forename: Deise Marcela
authors.initials: DM
authors.lastname: Piovesan
authors.forename: Diego Milan
authors.initials: DM
authors.lastname: Menegotto
authors.forename: Suzie
authors.initials: S
authors.lastname: Kang
authors.forename: Eduardo
authors.initials: E
authors.lastname: Franciscatto
authors.forename: Thaís
authors.initials: T
authors.lastname: Millan
authors.forename: Cristine
authors.initials: C
authors.lastname: Hoffmann
authors.forename: Lílian Rech
authors.initials: LR
authors.lastname: Pasin
authors.forename: Josiane
authors.initials: J
authors.lastname: Fischer
authors.forename: Sérgio Saldanha Menna
authors.initials: SS
authors.lastname: Barreto
authors.forename: Paulo de Tarso Roth
authors.initials: Pde T
authors.lastname: Dalcin
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000420:Albuterol / Q000008:administration & dosage; D001249:Asthma / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002648:Child; D004630:Emergencies; D004636:Emergency Service, Hospital; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D009241:Ipratropium / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate; D011379:Prognosis; D013997:Time Factors
chemical_list: D001993:Bronchodilator Agents; D009241:Ipratropium; D000420:Albuterol; D006854:Hydrocortisone